SPDR S&P Biotech ETF (XBI)

XBI
149.53 −9.58 (−6.02%) Delayed · as of Nov 5, 12:31 PM ET

How is SPDR S&P Biotech ETF (XBI) moving today?

SPDR S&P Biotech ETF (XBI) is down 6.02% today. A large move: 4.3× its typical day.

Updated 12:31 PM ET · Generated automatically from market data. How this works

AIAsk a follow-upAnswers from our data. Not advice.

Price

Key statistics Support & resistance →

Previous close
159.10
Day range
149.31 – 157.61
52-week range
108.04 – 169.55
1 week
−5.24%
1 month
−0.47%
3 months
−4.99%
Year to date
+22.63%
1 year
+37.95%
50-day average
155.66
200-day average
142.23
Volatility (20d, ann.)
35%
Typical daily move
1.4%

Analysis

SPDR S&P Biotech ETF (XBI) is at 149.53, down 6.0% today.

It is down 0.5% over the past month, up 22.6% so far this year and up 38.0% over 12 months.

It sits in the upper half of its 52-week range of 108.04 to 169.55, 11.8% below the high.

The price is above its 200-day average (142.23) and the 50-day average (155.66) is above the 200-day, a pattern usually read as an established uptrend.

Volatility over the past 20 sessions is 35% annualised, in line with the past year.

Generated automatically from price data, updated with every page load. Descriptive only; not investment advice.

About

The SPDR S&P Biotech ETF holds US biotechnology companies in roughly equal weights, so small drug developers count as much as large ones.

Related news

More etfs All →